Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.

Under the new proposal, like the previous one, members of the Sackler family would also give up ownership of Purdue ... family from civil lawsuits over OxyContin — even though the family ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates ...